Research and Development

Endoceutics drug pipeline

Endoceutics flagship product Intrarosa® is now approved in 38 countries, and launched in 18 countries, including Europe and the United States. The product is being registered in other strategic locations.

Endoceutics also has product candidates either in monotherapy or in combination that are currently in development.

Our research

A results-oriented approach and the implementation of effective solutions.


The new science of sex steroid physiology after menopause, 500 million years in the making.


Clinical Studies

It takes many years, many careful steps and a large number of participants to develop a safe and effective new therapy.

Our clinical studies